|
⚲
|
| Keyboard |
| Ed Hurwitz | |
|---|---|
| Firm | |
| Address | c/o Arialys Therapeutics, Inc 11099 North Torrey Pines Road, Suite 290 San Diego, CA 92037 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Arialys Therapeutics Inc | 021-550394 | Director | 14.8 M of 24.8 M |
||
| Arialys Therapeutics Inc | 021-466443 | Director | 14.3 M of 55.0 M |
||
| Biointervene Inc | 021-403933 | Director | 5.6 M of 5.6 M |
||
| Biointervene Inc | 021-335542 | Director | 3.1 M of 3.1 M |
||
| Rekindle Therapeutics Inc | 021-324935 | Director | 1.1 M of 6.5 M |
||
| Viewpoint Therapeutics Inc | 021-307759 | Director | 20.9 M of 35.0 M |
||
| Viewpoint Therapeutics Inc | 021-262446 | Executive Officer | 4.0 M of 4.0 M |
||
| Macrogenics Inc | 021-154617 | Director | 12.0 M of 12.0 M |
||
| Cara Therapeutics Inc | 021-145304 | Director | 4.8 M of 15.0 M |
||
| Sunesis Pharmaceuticals Inc | 021-144882 | Director | 28.5 M of 28.5 M |
||
| Taligen Therapeutics Inc | 021-80731 | Director | 36.0 M of 65.0 M |
||
| Sunesis Pharmaceuticals Inc | 021-47009 | Director | 10.0 M of 15.0 M |
||
| Calistoga Pharmaceuticals Inc | 021-97987 | Director | 15.0 M of 31.0 M |
||
| MPM Asset Management LLC | |||||
| MPM BioVentures 2018 B LP | 021-306340 | Executive Officer | of 400.0 M |
24.8 M | |
| MPM BioVentures 2018 LP | 021-306245 | Executive Officer | of 400.0 M |
483.2 M | |